Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-21-000041

EVP, Chief Financial Officer gave up 1,829 shares (to pay taxes)

  • EVP, Chief Financial Officer acquired 8,023 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LINDAHL RICHARD S · EVP, Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-24 Grant or award : show line 1 in the form +4,011 35,790 D
2021-02-24 Grant or award : show line 2 in the form +4,012 39,802 D
2021-02-24 Shares withheld for taxes : show line 3 in the form −1,010 $93.49 $94,425 38,792 D
2021-02-26 Shares withheld for taxes : show line 4 in the form −819 $97.15 $79,566 37,973 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-02-24 Grant or award : show line 5 in the form Employee Stock Options (Right to Buy) +16,043 $93.49 $1,499,860 16,043 D
Loading xslF345X03/wf-form4_161437750812785.xml…